SG Americas Securities’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
AIM
EIG
SG Americas Securities's TWST Position: Q2 2026 in Review
SG Americas Securities reduced its Twist Bioscience (TWST) stake by 78% in Q2 2026, selling an estimated $1.28M and leaving 5,407 shares worth $556K. The position accounts for ﹤0.01% of the portfolio, ranked #2254.
SG Americas Securities first reported a position in TWST in Q1 2020 and has held it in 21 quarters since. The position peaked at $2.89M in Q1 2021. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.
- SG Americas Securities held 5,407 shares of Twist Bioscience worth $556K as of Q2 2026.
- SG Americas Securities sold 19,663 Twist Bioscience shares in Q2 2026, an estimated $1.28M.
- Twist Bioscience made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2254 holding.
- SG Americas Securities first reported a position in Twist Bioscience in Q1 2020 and has held it in 21 quarters since.
- SG Americas Securities's Twist Bioscience position peaked at $2.89M in Q1 2021.
- 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.
Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.